Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist disclosure reporting period:   01/01/2023 - 06/30/2023
Lobbyist name Kristin Lewis   
Business name Point32Health
Address 1 Wellness Way   
City, state, zip code Canton, MA 02021         
Country US
Agent type Both
Phone 781-612-3621
 
 
Operating Expenses
No operating expenses were filed for this disclosure reporting period.
 
Activities, Bill Numbers and Titles
Client: Point32Health Services, Inc.
Total amount paid by client; lobbyist is unable to report compensation at activity level: $21,888.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 997 An Act to protect health care consumers from surprise billing Support $0.00 n/a
Senate Bill 665 An Act relative to specialty medications and patient safety Oppose $0.00 n/a
House Bill 1081 An Act relative to preserving preventative services without cost sharing Support $0.00 n/a
Senate Bill 689 An Act relative to patient access to biomarker testing to provide appropriate therapy Oppose $0.00 n/a
House Bill 1201 An Act to promote transparency in prescription drug prices Support $0.00 n/a
Executive Division of Insurance (Executive Office of Health and Human Services) Discussions with Division of Insurance on on Implementation of Amendments to Small Group Regulations Neutral $0.00 n/a
House Bill 1074 An Act relative to cancer patient access to biomarker testing to provide appropriate therapy Oppose $0.00 n/a
Senate Bill 677 An Act relative to prescription-drug utilization review Oppose $0.00 n/a
House Bill 1185 An Act strengthening market oversight of the Commonwealth's Health Care System Support $0.00 n/a
Senate Bill 749 An Act relative to pharmaceutical access, costs and transparency Support $0.00 n/a
House Bill 1 An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 n/a
Senate Bill 630 An Act ensuring access to specialty medications Oppose $0.00 n/a
Executive Executive Office of Health and Human Services (EOHHS) Discussions with Executive Office of Health and Human Services on Closure of Compass Medical Neutral $0.00 n/a
House Bill 986 An Act relative to telehealth and digital equity for patients Oppose $0.00 n/a
Senate Bill 655 An Act relative to telehealth and digital equity for patients Oppose $0.00 n/a
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Oppose $0.00 n/a
Senate Bill 736 An Act relative to the closing of hospital essential services Support $0.00 n/a
House Bill 1144 An Act relative to specialty medications and patient safety Oppose $0.00 n/a
Senate Bill 732 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Oppose $0.00 n/a
House Bill 1215 An Act relative to pharmacy benefit managers Oppose $0.00 n/a
Executive Massachusetts Health Policy Commission (HPC) Discussions with Health Policy Commission on Administrative Simplification Neutral $0.00 n/a
House Bill 1219 An Act enhancing the market review process Support $0.00 n/a
Executive Office of Medicaid/MassHealth (Executive Office of Health and Human Services) Discussions with MassHealth regarding Redeterminations Neutral $0.00 n/a
House Bill 3587 An Act to ensure access to prescription medications Oppose $0.00 n/a
Executive Department of Public Health (DPH) Discussions with Department of Public Health on Adult COVID-19 Vaccine Trust Fund Neutral $0.00 n/a
House Bill 1205 An Act relative to prescription drug price transparency Oppose $0.00 n/a
Executive Massachusetts Health Policy Commission (HPC) Discussions with Health Policy Commission on Affordability Agenda Neutral $0.00 n/a
Senate Bill 3 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 n/a
Executive Executive Office of Health and Human Services (EOHHS) Discussions with Executive Office of Health and Human Services on Temporary Suspension of Prior Authorization for Post-Acute Care Neutral $0.00 n/a
House Bill 945 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 n/a
Senate Bill 645 An Act relative to out-of-network billing Support $0.00 n/a
Executive Health Connector Discussion with the Massachusetts Health Connector on Seal of Approval Neutral $0.00 n/a
House Bill 979 An Act relative to transparency of hospital margins & ensuring hospital efficiency Support $0.00 n/a
Senate Bill 647 An Act relative to preserving preventive services without cost sharing Support $0.00 n/a
    Total amount $0.00  
Client: Point32Health Services, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 997 An Act to protect health care consumers from surprise billing Support $0.00 n/a
Senate Bill 665 An Act relative to specialty medications and patient safety Oppose $0.00 n/a
House Bill 1081 An Act relative to preserving preventative services without cost sharing Support $0.00 n/a
Senate Bill 689 An Act relative to patient access to biomarker testing to provide appropriate therapy Oppose $0.00 n/a
House Bill 1201 An Act to promote transparency in prescription drug prices Support $0.00 n/a
Executive Division of Insurance (Executive Office of Health and Human Services) Discussions with Division of Insurance on on Implementation of Amendments to Small Group Regulations Neutral $0.00 n/a
House Bill 1074 An Act relative to cancer patient access to biomarker testing to provide appropriate therapy Oppose $0.00 n/a
Senate Bill 677 An Act relative to prescription-drug utilization review Oppose $0.00 n/a
House Bill 1185 An Act strengthening market oversight of the Commonwealth's Health Care System Support $0.00 n/a
Senate Bill 749 An Act relative to pharmaceutical access, costs and transparency Support $0.00 n/a
House Bill 1 An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 n/a
Senate Bill 630 An Act ensuring access to specialty medications Oppose $0.00 n/a
Executive Executive Office of Health and Human Services (EOHHS) Discussions with Executive Office of Health and Human Services on Closure of Compass Medical Neutral $0.00 n/a
House Bill 986 An Act relative to telehealth and digital equity for patients Oppose $0.00 n/a
Senate Bill 655 An Act relative to telehealth and digital equity for patients Oppose $0.00 n/a
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Oppose $0.00 n/a
Senate Bill 736 An Act relative to the closing of hospital essential services Support $0.00 n/a
House Bill 1144 An Act relative to specialty medications and patient safety Oppose $0.00 n/a
Senate Bill 732 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Oppose $0.00 n/a
House Bill 1215 An Act relative to pharmacy benefit managers Oppose $0.00 n/a
Executive Massachusetts Health Policy Commission (HPC) Discussions with Health Policy Commission on Administrative Simplification Neutral $0.00 n/a
House Bill 1219 An Act enhancing the market review process Support $0.00 n/a
Executive Office of Medicaid/MassHealth (Executive Office of Health and Human Services) Discussions with MassHealth regarding Redeterminations Neutral $0.00 n/a
House Bill 3587 An Act to ensure access to prescription medications Oppose $0.00 n/a
Executive Department of Public Health (DPH) Discussions with Department of Public Health on Adult COVID-19 Vaccine Trust Fund Neutral $0.00 n/a
House Bill 1205 An Act relative to prescription drug price transparency Oppose $0.00 n/a
Executive Massachusetts Health Policy Commission (HPC) Discussions with Health Policy Commission on Affordability Agenda Neutral $0.00 n/a
Senate Bill 3 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 n/a
Executive Executive Office of Health and Human Services (EOHHS) Discussions with Executive Office of Health and Human Services on Temporary Suspension of Prior Authorization for Post-Acute Care Neutral $0.00 n/a
House Bill 945 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 n/a
Senate Bill 645 An Act relative to out-of-network billing Support $0.00 n/a
Executive Health Connector Discussion with the Massachusetts Health Connector on Seal of Approval Neutral $0.00 n/a
House Bill 979 An Act relative to transparency of hospital margins & ensuring hospital efficiency Support $0.00 n/a
Senate Bill 647 An Act relative to preserving preventive services without cost sharing Support $0.00 n/a
    Total amount $0.00  
Client: Point32Health Services, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 997 An Act to protect health care consumers from surprise billing Support $0.00 n/a
Senate Bill 665 An Act relative to specialty medications and patient safety Oppose $0.00 n/a
House Bill 1081 An Act relative to preserving preventative services without cost sharing Support $0.00 n/a
Senate Bill 689 An Act relative to patient access to biomarker testing to provide appropriate therapy Oppose $0.00 n/a
House Bill 1201 An Act to promote transparency in prescription drug prices Support $0.00 n/a
Executive Division of Insurance (Executive Office of Health and Human Services) Discussions with Division of Insurance on on Implementation of Amendments to Small Group Regulations Neutral $0.00 n/a
House Bill 1074 An Act relative to cancer patient access to biomarker testing to provide appropriate therapy Oppose $0.00 n/a
Senate Bill 677 An Act relative to prescription-drug utilization review Oppose $0.00 n/a
House Bill 1185 An Act strengthening market oversight of the Commonwealth's Health Care System Support $0.00 n/a
Senate Bill 749 An Act relative to pharmaceutical access, costs and transparency Support $0.00 n/a
House Bill 1 An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 n/a
Senate Bill 630 An Act ensuring access to specialty medications Oppose $0.00 n/a
Executive Executive Office of Health and Human Services (EOHHS) Discussions with Executive Office of Health and Human Services on Closure of Compass Medical Neutral $0.00 n/a
House Bill 986 An Act relative to telehealth and digital equity for patients Oppose $0.00 n/a
Senate Bill 655 An Act relative to telehealth and digital equity for patients Oppose $0.00 n/a
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Oppose $0.00 n/a
Senate Bill 736 An Act relative to the closing of hospital essential services Support $0.00 n/a
House Bill 1144 An Act relative to specialty medications and patient safety Oppose $0.00 n/a
Senate Bill 732 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Oppose $0.00 n/a
House Bill 1215 An Act relative to pharmacy benefit managers Oppose $0.00 n/a
Executive Massachusetts Health Policy Commission (HPC) Discussions with Health Policy Commission on Administrative Simplification Neutral $0.00 n/a
House Bill 1219 An Act enhancing the market review process Support $0.00 n/a
Executive Office of Medicaid/MassHealth (Executive Office of Health and Human Services) Discussions with MassHealth regarding Redeterminations Neutral $0.00 n/a
House Bill 3587 An Act to ensure access to prescription medications Oppose $0.00 n/a
Executive Department of Public Health (DPH) Discussions with Department of Public Health on Adult COVID-19 Vaccine Trust Fund Neutral $0.00 n/a
House Bill 1205 An Act relative to prescription drug price transparency Oppose $0.00 n/a
Executive Massachusetts Health Policy Commission (HPC) Discussions with Health Policy Commission on Affordability Agenda Neutral $0.00 n/a
Senate Bill 3 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 n/a
Executive Executive Office of Health and Human Services (EOHHS) Discussions with Executive Office of Health and Human Services on Temporary Suspension of Prior Authorization for Post-Acute Care Neutral $0.00 n/a
House Bill 945 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 n/a
Senate Bill 645 An Act relative to out-of-network billing Support $0.00 n/a
Executive Health Connector Discussion with the Massachusetts Health Connector on Seal of Approval Neutral $0.00 n/a
House Bill 979 An Act relative to transparency of hospital margins & ensuring hospital efficiency Support $0.00 n/a
Senate Bill 647 An Act relative to preserving preventive services without cost sharing Support $0.00 n/a
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateRecipient nameOffice soughtAmount
02/13/2023 Michael Rodrigues State Senator $200.00
05/08/2023 Karen Spilka State Senator $200.00
05/08/2023 Maura Healey Governor $100.00
06/29/2023 House Victory Fund n/a $100.00
  Total contributions $600.00
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us

Terms and Conditions     Accessibility Statement